Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129842 · ClinicalTrials.gov registry record
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A clinical trial of Atrial Fibrillation, sponsored by Itamar-Medical, Israel.
- Completed
- Registry status
- 150
- Enrollment target
- 6
- Study locations
NCT02129842: Completed study of Atrial Fibrillation, sponsored by Itamar-Medical, Israel.
NCT02129842 is a study of Atrial Fibrillation that has completed, run by Itamar-Medical, Israel. The registered enrollment target is 150 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02129842, a study of Atrial Fibrillation, has completed, sponsored by Itamar-Medical, Israel.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess whether normal endothelial function in patients with Atrial Fibrillation undergoing ablation procedure increases the chances of a favorable clinical outcome and maintaining sinus rhythm following ablation
Conditions Studied
Study Locations (6)
Other
- University Heart Center Hamburg - Hamburg
- Sheba Medical Center - Ramat Gan
- Royal Brompton & Harefield NHS Foundation Trust - London
New York
- New York University School of Medicine - New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-11 |
What the finished NCT02129842 record still lists
NCT02129842 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT02129842 lists 6 locations in 3 states (Other, New York, Texas).
Frequently Asked Questions
What is clinical trial NCT02129842 about?
NCT02129842 is a clinical study titled "Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?". The purpose of this study is to assess whether normal endothelial function in patients with Atrial Fibrillation undergoing ablation procedure increases the chances of a favorable clinical outcome and maintaining sinus rhythm following ablation
What is the current status of trial NCT02129842?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-05. Estimated completion is 2016-11.
What conditions does trial NCT02129842 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
Who is sponsoring clinical trial NCT02129842?
This trial is sponsored by Itamar-Medical, Israel, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02129842 being conducted?
This trial has 6 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02129842's enrollment target sits among peer trials
150 119th of 202 higher than 81 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia